MOH — authorised 24 September 1996
- Marketing authorisation holder: FRESENIUS KABI USA
- Status: likely_approved
MOH authorised Naropin on 24 September 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 24 September 1996.
FRESENIUS KABI USA holds the UAE marketing authorisation.